LAKE OSWEGO, Ore., Feb. 23, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet medical needs to advance cancer care, today announced that Rosemary Mazanet, M.D., Ph.D., Chief Medical Officer, will provide a presentation entitled, "Immunotherapy for Minimal Residual Disease- a Breast Cancer Vaccine to Prevent or Delay Recurrence Following Adjuvant Therapy" at the Cancer Immunotherapy Summit. The presentation will take place on Wednesday, February 29, 2012 at 10:15 AM EST at the Metro Meeting Centers in Boston, MA.
About Galena Biopharma
Galena Biopharma, Inc. (Nasdaq:GALE) is a Portland, Oregon-based biopharmaceutical company that develops innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care. For more information please visit us at www.galenabiopharma.com.
The Galena Biopharma, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=10647